Bausch Health Companies | VRX - Selling And Administration Expenses

Stock Price
6.82
Daily Change
-0.07 -1.02%
Monthly
-16.52%
Yearly
-33.59%
Q1 Forecast
6.65

Bausch Health Companies reported $801M in Selling and Administration Expenses for its fiscal quarter ending in December of 2025.





Selling And Administration Expenses Change Date
Amgen USD 1.94B 237M Dec/2025
ANI Pharmaceuticals USD 82.79M 6.13M Dec/2025
Aurora Cannabis CAD 41.79M 3.84M Sep/2025
Bausch Health Companies USD 801M 6M Dec/2025
Biogen USD 545.2M 38.6M Sep/2025
Bristol-Myers Squibb USD 2.18B 392M Dec/2025
Canopy Growth CAD 29.53M 999K Sep/2025
Corcept Therapeutics USD 114.74M 7.77M Dec/2025
Danaher USD 2.03B 35M Dec/2025
Drreddys Laboratories INR 26.92B 3.74B Dec/2025
Eli Lilly USD 3.13B 391.3M Dec/2025
Gilead Sciences USD 1.78B 425M Dec/2025
Nektar Therapeutics USD -0.18 0.07 Sep/2024
Novo Nordisk DKK 17.44B 1.41B Dec/2025
Pacira USD 91.87M 70K Dec/2025
Perrigo USD 255.9M 10.2M Dec/2025
Phibro Animal Health USD 76.34M 10.54M Dec/2024
Prestige Brands USD 29.67M 1.64M Dec/2025
Supernus Pharmaceuticals USD 122.39M 57.29M Dec/2025
Vertex Pharmaceuticals USD 487M 41.9M Dec/2025
Zoetis USD 619M 40M Dec/2025